Literature DB >> 19596360

Arginine vasopressin gene expression changes within the nucleus accumbens during environment elicited cocaine-conditioned response in rats.

E Rodríguez-Borrero1, F Rivera-Escalera, F Candelas, J Montalvo, W J Muñoz-Miranda, J R Walker, C S Maldonado-Vlaar.   

Abstract

It is known that changes in gene expression within the nucleus accumbens (NAc) occur during cocaine dependence development. However, identification of specific genes involved in cocaine conditioning awaits further investigation. We conducted a high throughput gene expression profile analysis of the NAc, during different stages of the environment-elicited cocaine conditioning. Rats were assigned to two different environmental conditions. Cocaine conditioned group received a cocaine injection (10mg/kg, i.p.) prior to being placed in the activity chambers. Control rats received saline injections before being exposed to their environment. Both groups received a saline injection in their home cage. Conditioning training lasted for 10 days. Animals were then re-exposed to their previously paired environments only on day 12 (test session). We found that the gene for arginine vasopressin (AVP) was differentially expressed on experimental subjects during all stages of environment-elicited cocaine conditioning. To further validate our molecular results, biochemical and immunolocalization experiments were conducted. We found the presence of AVP within accumbal fibers and changes in AVP protein levels following cocaine conditioning. Moreover, we tested the effects of accumbal microinfusions of either AVP receptor V(1A) agonist [pGlu(4), Cyt6, Arg(8)] AVP 4-9 1.0 ng/0.5 microl, or V(1A) antagonist (CH2) 5[Tyr (Me) 2] AVP, 1.0 ng/0.5 microl or vehicle solution (0.9% saline solution) during different stages of the cocaine conditioning. Blockade of V(1A) receptors within the NAc during acquisition interrupted the expression of the conditioned response, while activation leads to an increase in this response. Our findings propose a new role for AVP in cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596360      PMCID: PMC2783825          DOI: 10.1016/j.neuropharm.2009.06.040

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  50 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal: a DNA macroarray study.

Authors:  Shigenobu Toda; Jacqueline F McGinty; Peter W Kalivas
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

3.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

4.  Molecular pharmacology of human vasopressin receptors.

Authors:  M Thibonnier; D M Conarty; J A Preston; P L Wilkins; L N Berti-Mattera; R Mattera
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

Review 5.  Subcellular vasopressin mRNA trafficking and local translation in dendrites.

Authors:  E Mohr; D Richter
Journal:  J Neuroendocrinol       Date:  2004-04       Impact factor: 3.627

6.  Identification of chronic cocaine-induced gene expression through dopamine d1 receptors by using cDNA microarrays.

Authors:  Jianhua Zhang; Dongsheng Zhang; Ming Xu
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

7.  Effects of desglycinamide9, (Arg8) vasopressin and vasopressin antiserum on the acquisition of intravenous cocaine self-administration in the rat.

Authors:  J de Vry; I Donselaar; J M van Ree
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

8.  Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin.

Authors:  Yan Zhou; Francesco Leri; Erin Cummins; Marisa Hoeschele; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2007-04-18       Impact factor: 7.853

9.  [1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin.

Authors:  M Kruszynski; B Lammek; M Manning; J Seto; J Haldar; W H Sawyer
Journal:  J Med Chem       Date:  1980-04       Impact factor: 7.446

Review 10.  The neurobiology of cocaine addiction.

Authors:  Eric J Nestler
Journal:  Sci Pract Perspect       Date:  2005-12
View more
  12 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

2.  Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Mauro A M Carai; Ann Ho; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2011-05-16       Impact factor: 3.455

3.  Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.

Authors:  Yan Zhou; Yoav Litvin; Anna Paola Piras; Donald W Pfaff; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2011-06-15       Impact factor: 7.853

4.  Anxiolytic effects of oxytocin in cue-induced cocaine seeking behavior in rats.

Authors:  Amarilys Morales-Rivera; Mayté M Hernández-Burgos; Arlene Martínez-Rivera; Jeremy Pérez-Colón; Raymond Rivera; Janitza Montalvo; Enrique Rodríguez-Borrero; Carmen S Maldonado-Vlaar
Journal:  Psychopharmacology (Berl)       Date:  2014-04-24       Impact factor: 4.530

5.  Metabotropic glutamate receptor 5 within nucleus accumbens shell modulates environment-elicited cocaine conditioning expression.

Authors:  Arlene Martínez-Rivera; Enrique Rodríguez-Borrero; María Matías-Alemán; Alexandra Montalvo-Acevedo; Kathleen Guerrero-Figuereo; Liz J Febo-Rodríguez; Amarilys Morales-Rivera; Carmen S Maldonado-Vlaar
Journal:  Pharmacol Biochem Behav       Date:  2013-07-10       Impact factor: 3.533

Review 6.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

Review 7.  Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Authors:  M Manning; A Misicka; A Olma; K Bankowski; S Stoev; B Chini; T Durroux; B Mouillac; M Corbani; G Guillon
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

8.  Removal of vasopressin cells from the paraventricular nucleus of the hypothalamus enhances lipopolysaccharide-induced sickness behaviour in mice.

Authors:  Jack Whylings; Nicole Rigney; Geert J de Vries; Aras Petrulis
Journal:  J Neuroendocrinol       Date:  2020-12-07       Impact factor: 3.627

9.  Effects of cocaine on maternal behavior and neurochemistry.

Authors:  Benjamin C Nephew; Marcelo Febo
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

10.  Enhanced upregulation of CRH mRNA expression in the nucleus accumbens of male rats after a second injection of methamphetamine given thirty days later.

Authors:  Jean Lud Cadet; Christie Brannock; Bruce Ladenheim; Michael T McCoy; Irina N Krasnova; Elin Lehrmann; Kevin G Becker; Subramaniam Jayanthi
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.